Psychotic Disorders  >>  risperidone  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

20 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
risperidone / Generic mfg.
NCT00515489: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Terminated
N/A
1882
Europe
Risperidone
Janssen-Cilag, S.A.
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders
 
08/02
NCT00511628: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia

Terminated
N/A
1717
Europe
Risperidone
Janssen-Cilag, S.A.
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
 
01/03
NCT00015548: CATIE-Alzheimer's Disease Trial

Completed
N/A
450
US
Olanzapine, Quetiapine, Risperidone, Citalopram
National Institute of Mental Health (NIMH)
Alzheimer's Disease
 
10/04
NCT00012558: Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Completed
N/A
5000
US
lithium, valproate, bupropion, paroxetine, lamotrigine, risperidone, inositol, tranylcypromine, Cognitive Behavioral Therapy, Family-focused Therapy, Interpersonal and Social Rhythms Therapy
National Institute of Mental Health (NIMH)
Bipolar Disorder
 
09/05
NCT00174200: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Completed
N/A
20
Canada, RoW
Risperidone 2 mg
Pfizer
Schizophrenia, Psychotic Disorders
 
05/06
NCT00287027: Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication

Terminated
N/A
60
US
Risperdal Long Acting Injectable Antipsychotic Medication
National Alliance on Mental Illness New Hampshire, Janssen Medical Affairs
Psychotic Disorders
 
12/06
NCT00169988: Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

Completed
N/A
8
US
risperidone, sertraline-primary
Northwell Health, Stanley Medical Research Institute, Janssen Pharmaceutica N.V., Belgium, Pfizer
Prodromal Schizophrenia, Psychotic Disorders
 
04/07
NCT00179062: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Completed
N/A
300
US
olanzapine versus risperidone
Vanderbilt University
Schizophrenia, Schizoaffective Disorder, Depressive Disorder, Major, Bipolar Disorder
06/07
06/07
NCT00644852: Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

Completed
N/A
342
RoW
Retrospective chart review study
Johnson & Johnson Taiwan Ltd
Schizophrenia, Schizoaffective Disorder
09/07
09/07
e-STAR, NCT00774085: An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone

Completed
N/A
408
Europe
No intervention was given
Janssen Cilag N.V./S.A.
Schizophrenia
12/07
12/07
NCT00312598: Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Completed
N/A
30
US
Aripiprazole, Abilify
University of North Carolina, Chapel Hill, Bristol-Myers Squibb
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Mood Disorders
04/10
04/10
NCT01043250: Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Completed
N/A
81
RoW
Samsung Medical Center, Ministry of Health & Welfare, Korea, Korea Otsuka Pharmaceutical Co., Ltd.
Schizophrenia, Schizoaffective Disorder
04/10
12/10
NCT00783783: CYP2D6 Pharmacogenetics in Risperidone-Treated Children

Completed
N/A
47
US
Children's Hospital Medical Center, Cincinnati, Ohio State University, Rainbow Babies and Children's Hospital
Psychiatric Disorders, Neurodevelopmental Disorders
06/11
06/11
NCT01770600: Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression

Withdrawn
N/A
0
US
placebo, Riperidone, risperdal
University of Alabama at Birmingham
Impulsivity, Active Suicidal Ideation, Depression
09/13
 
NCT01181960: Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Completed
N/A
1066
US
Risperidone long acting injectable - New Starts, Risperidone long acting injectable - Continuous Users, Paliperidone Palmitate -New and Continuous Users, Other Antipsychotics - New Starts
Janssen Scientific Affairs, LLC
Schizophrenia, Bipolar Disorder
11/13
11/13
NCT01786239: Omega-3 Dietary Supplements in Schizophrenia

Completed
N/A
50
US
Risperidone, Risperdal, Omega-3 capsules, Omega-3, Placebo, Placebo capsules
Delbert Robinson, National Institute of Mental Health (NIMH), National Alliance for Research on Schizophrenia and Depression
Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Bipolar Disorder, Psychosis NOS
09/15
09/15
NCT01739127: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Completed
N/A
83
Canada
Aripiprazole, ABILIFY, Risperidone/Quetiapine, Risperdal, Apo-risperidone, Seroquel, Apo-quetiapine
University of British Columbia, Bristol-Myers Squibb
Psychotic Disorders, Bipolar Disorder, Metabolic Syndrome X
02/16
02/16
NCT01686815: Cross-Sectional Iloperidone IVGTT

Completed
N/A
37
US
Massachusetts General Hospital, Novartis Pharmaceuticals
Schizophrenia, Serious Mental Illness, Metabolic Syndrome, Insulin Resistance, Glucose Metabolism
05/16
05/16
NCT01878513: Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

Completed
N/A
88
US
risperidone, Risperdal
Northwell Health
Schizophrenia, Schizoaffective Disorder, Psychotic Disorder Not Otherwise Specified, Severe Bipolar Disorder With Psychotic Features
07/18
07/18
NCT02034253: Glutamate, Brain Connectivity and Duration of Untreated Psychosis

Completed
N/A
134
US
Risperidone, Risperdal
University of Alabama at Birmingham
Schizophrenia, Psychosis, Schizoaffective Disorder
11/18
11/18

Download Options